Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential uses
Open Access
- 1 December 1996
- journal article
- review article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 35 (6) , 969-979
- https://doi.org/10.1016/s0190-9622(96)90122-x
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Treatment of cutaneous and pulmonary sarcoidosis with thalidomideJournal of the American Academy of Dermatology, 1995
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993
- Thalidomide: Treatment of choice for aphthous ulcers in patients seropositive for human immunodeficiency virusJournal of the American Academy of Dermatology, 1993
- Thalidomide in Human Immunodeficiency Virus (HIV) PatientsDrug Safety, 1992
- Pyoderma gangrenosum associated with Behçet's disease: Treatment with thalidomideJournal of the American Academy of Dermatology, 1990
- Recurrent aphthous ulcer in patient infected with human immunodeficiency virus: Successful treatment with thalidomideJournal of the American Academy of Dermatology, 1990
- Significant response of oral aphthosis to thalidomide treatmentJournal of the American Academy of Dermatology, 1985
- Studies on the anti-inflammatory properties of thalidomide: Effects on polymorphonuclear leukocytes and monocytesJournal of the American Academy of Dermatology, 1984
- Thalidomide for autoimmune diseaseMedical Hypotheses, 1983
- Thalidomide: Use and possible mode of action in reactional lepromatous leprosy and in various other conditionsJournal of the American Academy of Dermatology, 1982